Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SS-LUP-332 Results After 1 Week: REV-ERBα Agonist Comparison

This table shows how SS-LUP-332 compares to other metabolic modulators at the one-week mark. SS-LUP-332 REV-ERBα agonist 12–18% (RER shift) Minimal to none Moderate (5–8% longer time to fatigue) Best for metabolic priming. Visible results require 4–6 weeks Tes

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • This table shows how SS-LUP-332 compares to other metabolic modulators at the one-week mark.
  • SS-LUP-332
  • REV-ERBα agonist
  • 12–18% (RER shift)
  • Minimal to none
  • Moderate (5–8% longer time to fatigue)
  • Best for metabolic priming. Visible results require 4–6 weeks
  • Tesofensine
  • Monoamine reuptake inhibitor
  • Minimal
  • 0.5–1.2 kg loss
  • None
  • Appetite suppression drives early weight loss, not metabolic shift
  • Cardarine (GW501516)
  • PPARδ agonist
  • 15–22% (similar pathway)
  • High (10–15% endurance gain)
  • Faster endurance response, similar fat oxidation timeline
  • L-Carnitine
  • Fatty acid transport cofactor
  • 3–5%
  • Supports oxidation but doesn't upregulate mitochondrial machinery